Security record · archived quarter
CVS
CVS Health Corp. · Healthcare · Medical - Healthcare Plans
4Tracked holders
+1Δ holders
4.62MShares held
$393.86MReported value
+1New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2026
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 4 | +1 | 4.62M | $393.86M | +1 | n/a |
| Q2 2026 | 183 | +1 | 959.03M | $99.10B | +4 | −2 |
| Q1 2026 | 184 | -5 | 933.53M | $67.00B | +1 | −7 |
| Q4 2025 | 188 | -1 | 988.04M | $78.39B | +1 | −1 |
| Q3 2025 | 31 | +1 | 672.14M | $50.66B | +1 | −1 |
| Q2 2025 | 28 | +1 | 592.40M | $40.85B | +1 | n/a |
| Q1 2025 | 24 | 0 | 305.08M | $20.66B | +1 | −1 |
| Q4 2024 | 24 | -1 | 290.03M | $13.02B | +1 | −2 |
| Q3 2024 | 24 | +2 | 213.06M | $13.39B | +3 | −1 |
| Q2 2024 | 22 | n/a | 197.40M | $11.65B | n/a | n/a |
Who holds it · Q3 2026
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Assenagon Asset Management S.A. | 3.81M | +7.3% | $326.70M | 0.3% | ▲ Add | 4 | SEC ↗ |
| 2 | Wealth Enhancement Advisory… | 495.49K | +15.7% | $40.63M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 3 | TD Waterhouse Canada Inc. | 310.26K | -31.4% | $26.44M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 4 | Ninety One UK Ltd | 935 | New | $80,121 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Ninety One UK Ltd | $80,121 | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1,848 holders, 1.07B shares, $73.55B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q3 2026 ·
Methodology ·
Get this via the API